These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9625484)

  • 1. Genetic toxicology.
    Kramer PJ
    J Pharm Pharmacol; 1998 Apr; 50(4):395-405. PubMed ID: 9625484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxicity testing: current practices and strategies used by the pharmaceutical industry.
    Purves D; Harvey C; Tweats D; Lumley CE
    Mutagenesis; 1995 Jul; 10(4):297-312. PubMed ID: 7476265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
    Warheit DB; Donner EM
    Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact.
    Müller L; Kikuchi Y; Probst G; Schechtman L; Shimada H; Sofuni T; Tweats D
    Mutat Res; 1999 May; 436(3):195-225. PubMed ID: 10354523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of U. S. National Toxicology Program (NTP) mouse lymphoma assay data using International Workshop on Genotoxicity Tests (IWGT) and the Organization for Economic Co-Operation and Development (OECD) criteria.
    Schisler MR; Gollapudi BB; Moore MM
    Environ Mol Mutagen; 2018 Dec; 59(9):829-841. PubMed ID: 30357906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity guidelines recommended by International Conference of Harmonization (ICH).
    Kamath GH; Rao KS
    Methods Mol Biol; 2013; 1044():431-58. PubMed ID: 23896892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of published data for top concentration considerations in mammalian cell genotoxicity testing.
    Parry JM; Parry E; Phrakonkham P; Corvi R
    Mutagenesis; 2010 Nov; 25(6):531-8. PubMed ID: 20720196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up testing of rodent carcinogens not positive in the standard genotoxicity testing battery: IWGT workgroup report.
    Kasper P; Uno Y; Mauthe R; Asano N; Douglas G; Matthews E; Moore M; Mueller L; Nakajima M; Singer T; Speit G;
    Mutat Res; 2007 Feb; 627(1):106-16. PubMed ID: 17123861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a high-throughput transcriptomic biomarker to address 21st century genetic toxicology needs.
    Li HH; Chen R; Hyduke DR; Williams A; Frötschl R; Ellinger-Ziegelbauer H; O'Lone R; Yauk CL; Aubrecht J; Fornace AJ
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10881-E10889. PubMed ID: 29203651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to assess the mutagenic potential of cosmetic products without animal tests?
    Speit G
    Mutat Res; 2009 Aug; 678(2):108-12. PubMed ID: 19379833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxicity screening: the slow march to the future.
    Walmsley RM
    Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):261-8. PubMed ID: 16922641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory recognition of indirect genotoxicity mechanisms in the European Union.
    Pratt IS; Barron T
    Toxicol Lett; 2003 Apr; 140-141():53-62. PubMed ID: 12676451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of the mutagenicity/genotoxicity data of the cosmetic ingredients present on the Annexes of the Cosmetic EU legislation (2000-12).
    Ates G; Doktorova TY; Pauwels M; Rogiers V
    Mutagenesis; 2014 Mar; 29(2):115-21. PubMed ID: 24435663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in genotoxicology: Acceptance of innovative scientific methods in a regulatory context and from an industrial perspective.
    Steiblen G; Benthem JV; Johnson G
    Mutat Res Genet Toxicol Environ Mutagen; 2020 May; 853():503171. PubMed ID: 32522346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic toxicology: can we design predictive in vivo assays?
    Clive D
    Mutat Res; 1988; 205(1-4):313-30. PubMed ID: 3285193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.